Dr. Joseph Dasta, adjunct professor of pharmacy practice, has been named recipient of the American Society of Health-System Pharmacists Research and Education Foundation's 2010 Award for Sustained Contributions to the Literature of Pharmacy Practice.
He was recognized by the Foundation at the 2010 ASHP Midyear Clinical Meeting in December.
"This recognition is especially meaningful to me since it is from my peers in the hospital pharmacy field," said Dasta. "I am fortunate to have collaborated with so many talented people. I share this award with my colleagues in pharmacy, medicine, nursing and respiratory therapy. One of my hopes is that this research has stimulated others to attempt to answer additional questions generated from my findings with the goal of improving the care of the critically ill and injured patient. My deepest thanks go to the ASHP Foundation."
The Literature Awards Program honors important contributions by pharmacists to the biomedical literature. All Literature Award recipients exemplify excellence in research and writing that foster improvements in patient care medication use, pioneer new uses of technology and pharmacy personnel and demonstrate the pharmacist's role in patient care.
Dasta has published in the pharmacy and medical literature for 33 years. His body of work involves articles on pulmonary medicine; pharmacotherapeutic and economic outcomes in critically ill patients, focusing mainly on pharmacotherapeutic practice patterns and developing the pharmacist's role in the critical care setting; and pharmacoeconomics and health outcomes of critical illnesses.
He wrote the first study to compare sustained-release to conventional release theophylline
tablets in patients with chronic obstructive pulmonary disease. He also was among the first to attempt to understand intensive care unit (ICU) pharmacotherapy, describing alterations in their pharmacokinetics and documenting suboptimal use of sedatives. His 1982 editorial on critical care therapeutics was the first paper to identify the ICU as an important area for pharmacist contributions and was followed by the first textbook on The Practice of Critical Care Pharmacy in 1985, which he co-edited. This helped set the
stage for the increasing role of the critical care pharmacist.
The studies he conducted in ICU patients demonstrated the additional role a pharmacist can play in conducting critical care research. Three of his surveys of critical care pharmacy over a 10-year period demonstrated the increased involvement of the ICU pharmacist both within and outside of the United States.
His later work collectively emphasize the high cost of acute illness and the opportunity to reduce the costs associated with unnecessary or inappropriate therapy, including sedatives. He has shown that optimal pharmacotherapy is about total cost of care, not simply the acquisition drug cost.